Documentation of Harm: Evidence of the financial and personal impact of the injury, including medical bills, pay stubs, and personal journals detailing the daily effects of the condition
(PubMed) Keith M, Mazer CD, Mikhail P, Jeejeebhoy F, Briet F, Errett L
Anti-tumour necrosis factor monoclonal antibodies Infliximab and adalimumab are licensed for both UC and CD with comparable efficacy, while golimumab is currently licensed for UC only[7073]
Reframing chronic pain as a disease, not a symptom: rationale and implications for pain management
What sets Dannielli apart is not just her talent, but her passion for helping others feel their absolute best
The survival period of the MMNST is very short, generally not more than one year